Profile
CRVO VRTX REGN VRNA ARGX ALNY
Company Name CervoMed Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $44.41M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.02K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO John J. Alam Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
CRVO VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
CRVO VRTX REGN VRNA ARGX ALNY
Last Close $8.21 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $14.29 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $1.9 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -42.55 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 332.11 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
CRVO VRTX REGN VRNA ARGX ALNY
1 Month Return 15.96 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -16.48 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -6.49 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 268.16 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 250.85 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -18.55 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CRVO VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -4985036.4 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
CRVO VRTX REGN VRNA ARGX ALNY
Asset Growth 332 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth - 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -133.3 % 9.09 % -131.37 % 24.59 %
Net Income Growth -650.08 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 89.1 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 98.47 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 99.98 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -133.3 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -121.89 % - -143.33 % -107.98 %
Operating 3 Year CFG 81.62 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 98.14 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 99.97 % -100 % 40.15 % 97.08 %
EPS Growth -146.34 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth -146.34 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 75.17 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -81.89 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -97.84 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -99.98 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth - 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -121.89 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
CRVO VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 100 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -83.58 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -76.78 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -104.59 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 94.05 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -8433.6 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 0.24 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 1.05 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -2.69 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -2.69 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 294.98 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -7727.09 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -1.78 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -1.78 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -1.78 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
CRVO VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.02B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.02B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -2.02 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
CRVO VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.04B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0.03B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.04B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
CRVO VRTX REGN VRNA ARGX ALNY
Net Income $-0.02B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.345
AARD Aardvark Therapeutics, Inc. Common Stock 12.27
ABCL AbCellera Biologics Inc. 2.94
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.995
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.395
ABPWW 0.0131
ABSI Absci Corporation 2.415
ABUS Arbutus Biopharma Corporation 4.01
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.35
ACAD ACADIA Pharmaceuticals Inc. 21.605
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.74
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.13
ACIU AC Immune SA 2.93
ETFs With Exposure to CRVO
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00008 259.54
VTI Vanguard Total Stock Market Index Fund 0.0001 336.15
IWO iShares Russell 2000 Growth ETF 0.00014 331.155
VXF Vanguard Extended Market Index Fund 0.00062 213.895
HDG ProShares Hedge Replication ETF 0.000195933 52.7299
UWM ProShares Ultra Russell2000 0.00115528 51.77
VTHR Vanguard Russell 3000 Index Fund 0 301.07
IWC iShares Micro-Cap ETF 0.01 164.58
URTY ProShares UltraPro Russell2000 0.00092375 60.85
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0 78.42
VTWG Vanguard Russell 2000 Growth Index Fund 0.00302 241.62
VTWO Vanguard Russell 2000 Index Fund 0.00157 104.88
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 49.11
VUN.TO Vanguard U.S. Total Market Index ETF 0.0001 124.31
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00009 116.64
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00005 115
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 114.98
VGRO.TO Vanguard Growth ETF Portfolio 0.00003 43.93
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00004 55.12
VBAL.TO Vanguard Balanced ETF Portfolio 0.00003 37.61
VCNS.TO Vanguard Conservative ETF Portfolio 0.00002 32.01
VCIP.TO Vanguard Conservative Income ETF Portfolio 0.00001 27.34
VRIF.TO Vanguard Retirement Income ETF Portfolio 0.00001 26.94
BMED BlackRock Future Health ETF 0.01001 30.4
VTSAX Vanguard Total Stock Market Index Fund 0.0001 166.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00062 165.55
VITSX Vanguard Total Stock Market Index Fund 0.0001 166.27
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00062 165.56
AVSC Avantis U.S. Small Cap Equity ETF 0 63.99
VTS.AX Vanguard US Total Market Shares Index ETF 0.0001 481.52
VEMPX Vanguard Extended Market Index InstlPlus 0.00062 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.0001 311.9
RSSL Global X Funds 0 101.72
Unlock